furosemide has been researched along with Osteosarcoma in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"A 13-year-old girl with osteosarcoma and pulmonary metastases developed life-threatening renal toxicity, encephalopathy, and bone marrow failure following high dose methotrexate therapy." | 4.76 | [(Management of acute toxicity after high dose methotrexate therapy)]. ( Kotz, R; Krisch, K; Mutz, I; Urban, C, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Urban, C | 1 |
Mutz, I | 1 |
Kotz, R | 1 |
Krisch, K | 1 |
Khademazad, M | 1 |
Zhang, BX | 1 |
Loessberg, P | 1 |
Muallem, S | 1 |
Dixon, SJ | 1 |
Kulaga, A | 1 |
Jaworski, EM | 1 |
Wilson, JX | 1 |
1 review available for furosemide and Osteosarcoma
Article | Year |
---|---|
[(Management of acute toxicity after high dose methotrexate therapy)].
Topics: Adolescent; Blood Transfusion; Brain; Dose-Response Relationship, Drug; Female; Fluid Therapy; Furos | 1979 |
2 other studies available for furosemide and Osteosarcoma
Article | Year |
---|---|
Regulation of cell volume by the osteosarcoma cell line UMR-106-01.
Topics: 1-Methyl-3-isobutylxanthine; Amiloride; Animals; Calcium; Cell Line; Cell Membrane Permeability; Cyt | 1991 |
Ascorbate uptake by ROS 17/2.8 osteoblast-like cells: substrate specificity and sensitivity to transport inhibitors.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfo | 1991 |